| J9271 | Injection, pembrolizumab, 1 mg | 16,000 | $40 | $688K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,110 | $90 | $100.1K |
| J0897 | Injection, denosumab, 1 mg | 4,380 | $20 | $78.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 550 | $90 | $51.9K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 490 | $90 | $43.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 550 | $60 | $33.1K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 21,750 | $1 | $21.8K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 150 | $140 | $20.1K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 400 | $20 | $8.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 160 | $50 | $7.1K |